Skip to content
2000
Volume 21, Issue 1
  • ISSN: 1573-4056
  • E-ISSN: 1875-6603
side by side viewer icon HTML

Abstract

Background

There remains a lack of methods to accurately assess the efficacy of neoadjuvant chemoradiotherapy for locally advanced rectal cancer.

Objective

This study aimed to investigate the value of shear-wave elastography in evaluating the treatment response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer.

Materials and Methods

This prospective observational study enrolled 275 patients with locally advanced rectal cancer who received neoadjuvant chemoradiotherapy during September 2021–March 2023. All patients underwent endorectal ultrasound and shear-wave elastography examination before total mesorectal excision. Clinical baseline data, endorectal ultrasound, and shear-wave elastography examination data were collected from all patients. The independent predictors of complete response were analyzed and screened, followed by the establishment of a logistic regression model. The diagnostic efficacy of the model was compared with that of radiologists.

Results

The results of binary multivariate logistic regression suggested that the mean elastography value of the tumor lesion acted as an independent predictor for the diagnosis of complete response [OR: 0.894 (0.816, 0.981)]. The optimal cutoff value was 14.6 kPa. The area under the receiver operating characteristic curve of the model for predicting complete response in the training and test cohorts was 0.850 and 0.824, respectively. The diagnostic accuracy of the model was significantly higher than that of radiologists (P < 0.001).

Conclusion

Shear-wave elastography can be used as a feasible method to evaluate the complete response of locally advanced rectal cancer after neoadjuvant chemoradiotherapy.

© 2025 The Author(s). Published by Bentham Science Publishers. This is an open access article published under CC BY 4.0 https://creativecommons.org/licenses/by/4.0/legalcode
Loading

Article metrics loading...

/content/journals/cmir/10.2174/0115734056327323250108055841
2025-01-01
2025-10-25
Loading full text...

Full text loading...

/deliver/fulltext/cmir/21/1/CMIR-21-E15734056327323.html?itemId=/content/journals/cmir/10.2174/0115734056327323250108055841&mimeType=html&fmt=ahah

References

  1. SungH. FerlayJ. SiegelR.L. LaversanneM. SoerjomataramI. JemalA. BrayF. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J. Clin.202171320924910.3322/caac.2166033538338
    [Google Scholar]
  2. NCCN Guidelines.2022Available from: https://www.nccn.org/guidelines/category_1
  3. VogelJ.D. FelderS.I. BhamaA.R. HawkinsA.T. LangenfeldS.J. ShafferV.O. ThorsenA.J. WeiserM.R. ChangG.J. LightnerA.L. FeingoldD.L. PaquetteI.M. The American society of colon and rectal surgeons clinical practice guidelines for the management of colon cancer.Dis. Colon Rectum202265214817710.1097/DCR.000000000000232334775402
    [Google Scholar]
  4. Glynne-JonesR. WyrwiczL. TiretE. BrownG. RödelC. CervantesA. ArnoldD. ESMO Guidelines Committee Corrections to “rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up”.Ann. Oncol.201829Suppl. 4iv26310.1093/annonc/mdy16129741565
    [Google Scholar]
  5. LoughreyM.B. QuirkeP. ShepherdN.A. Standards and datasets for reporting cancers Dataset for histopathological reporting of colorectal cancer April 2023.2023Available from: https://www.rcpath.org/profession/guidelines/cancer-datasets-and-tissue-pathways.html
  6. LiJ. HuangX. GaoP. SongY. ChenX. LvX. FuY. XiaoQ. YeS. WangZ. Survival landscape of different tumor regression grades and pathologic complete response in rectal cancer after neoadjuvant therapy based on reconstructed individual patient data.BMC Cancer2021211121410.1186/s12885‑021‑08922‑134773999
    [Google Scholar]
  7. ChenH.Y. FengL.L. LiM. JuH.Q. DingY. LanM. SongS.M. HanW.D. YuL. WeiM.B. PangX.L. HeF. LiuS. ZhengJ. MaY. LinC.Y. LanP. HuangM.J. ZouY.F. YangZ.L. WangT. LangJ.Y. OrangioG.R. PoylinV. AjaniJ.A. WangW.H. WanX.B. College of American pathologists tumor regression grading system for long-term outcome in patients with locally advanced rectal cancer.Oncologist2021265e780e79310.1002/onco.1370733543577
    [Google Scholar]
  8. NagtegaalI.D. Glynne-JonesR. How to measure tumour response in rectal cancer? An explanation of discrepancies and suggestions for improvement.Cancer Treat. Rev.20208410196410.1016/j.ctrv.2020.10196432000055
    [Google Scholar]
  9. KimJ.Y. ParkI.J. HongS.M. LeeJ.L. YoonY.S. KimC.W. LimS.B. LeeJ.B. YuC.S. KimJ.C. Is pathologic near-total regression an appropriate indicator of a good response to preoperative chemoradiotherapy based on oncologic outcome of disease?Medicine20159450e225710.1097/MD.000000000000225726683945
    [Google Scholar]
  10. VailatiB.B. São JuliãoG.P. Habr-GamaA. PerezR.O. Nonoperative management of rectal cancer.Surg. Oncol. Clin. N. Am.202231217118210.1016/j.soc.2021.11.00335351272
    [Google Scholar]
  11. GrotenhuisB.A. BeetsG.L. Watch-and-wait is an option in rectal cancer patients: From controversy to common clinical practice.Clin. Oncol. (R. Coll. Radiol.)202335212412910.1016/j.clon.2022.11.01136481218
    [Google Scholar]
  12. CongY. FanZ. DaiY. ZhangZ. YanK. Application value of shear wave elastography in the evaluation of tumor downstaging for locally advanced rectal cancer after neoadjuvant chemoradiotherapy.J. Ultrasound Med.2021401818910.1002/jum.1537832648968
    [Google Scholar]
  13. CoteA. FlorinF.G. MoisE. EliseiR. BadeaR. MareC. HajjarN.A. IancuC. LeboviciA. The accuracy of endorectal ultrasonography and high-resolution magnetic resonance imaging for restaging rectal cancer after neoadjuvant chemoradiotherapy.Ann. Ital. Chir.201889216817629848812
    [Google Scholar]
  14. B. AminMahul AJCC Cancer Staging ManualSpringerNew York20172632642017
    [Google Scholar]
  15. DaydeD. TanakaI. JainR. TaiM. TaguchiA. Predictive and prognostic molecular biomarkers for response to neoadjuvant chemoradiation in rectal cancer.Int. J. Mol. Sci.201718357310.3390/ijms1803057328272347
    [Google Scholar]
  16. ZhaoJ.Y. TangQ.Q. LuoY.T. WangS.M. ZhuX.R. WangX.Y. Predictive value of a serum tumor biomarkers scoring system for clinical stage II/III rectal cancer with neoadjuvant chemoradiotherapy.World J. Gastrointest. Oncol.202214102014202410.4251/wjgo.v14.i10.201436310703
    [Google Scholar]
  17. ShanJ. GuB. ShiL. WangX. YeW. ZhouW. SunX. Prognostic value of CEA and CA19-9 in patients with local advanced rectal cancer receiving neoadjuvant chemoradiotherapy, radical surgery and postoperative chemotherapy.Transl. Cancer Res.2021101889810.21037/tcr‑20‑226935116242
    [Google Scholar]
  18. CaiZ. HuangL. ChenY. XieX. ZouY. LanP. WuX. CEA decline predicts tumor regression and prognosis in locally advanced rectal cancer patients with elevated baseline CEA.J. Cancer202011226565657010.7150/jca.4925233046977
    [Google Scholar]
  19. MaierA.M. HeilJ. HarcosA. SinnH.P. RauchG. UhlmannL. GomezC. StieberA. FunkA. BarrR.G. HennigsA. RiedelF. SchäfgenB. HugS. MarméF. SohnC. GolattaM. Prediction of pathological complete response in breast cancer patients during neoadjuvant chemotherapy: Is shear wave elastography a useful tool in clinical routine?Eur. J. Radiol.202012810902510.1016/j.ejrad.2020.10902532371182
    [Google Scholar]
  20. EvansA. SimY.T. PourreyronC. ThompsonA. JordanL. FlemingD. PurdieC. MacaskillJ. VinnicombeS. PharoahP. Pre-operative stromal stiffness measured by shear wave elastography is independently associated with breast cancer-specific survival.Breast Cancer Res. Treat.2018171238338910.1007/s10549‑018‑4836‑529858751
    [Google Scholar]
  21. RubioI.T. SobridoC. Neoadjuvant approach in patients with early breast cancer: Patient assessment, staging, and planning.Breast202262Suppl 1Suppl. 1S17S2410.1016/j.breast.2021.12.01934996668
    [Google Scholar]
  22. EvansA. SimY.T. LawsonB. MacaskillJ. JordanL. ThompsonA. The value of prognostic ultrasound features of breast cancer in different molecular subtypes with a focus on triple negative disease.Breast Cancer202229229630110.1007/s12282‑021‑01311‑334780035
    [Google Scholar]
  23. QianQ. ZhuoM. ChenX. Shear-wave elastography predicts T-restaging and pathologic complete response of rectal cancer post neoadjuvant chemoradiotherapy.Abdom. Radiol.2024492561257310.1007/s00261‑024‑04361‑138806703
    [Google Scholar]
  24. ZhangJ. TanX. ZhangX. KangY. LiJ. RenW. MaY. Efficacy of shear-wave elastography versus dynamic optical breast imaging for predicting the pathological response to neoadjuvant chemotherapy in breast cancer.Eur. J. Radiol.202012910909810.1016/j.ejrad.2020.10909832559591
    [Google Scholar]
  25. MaY. ZhangS. ZangL. LiJ. LiJ. KangY. RenW. Combination of shear wave elastography and Ki-67 index as a novel predictive modality for the pathological response to neoadjuvant chemotherapy in patients with invasive breast cancer.Eur. J. Cancer2016698610110.1016/j.ejca.2016.09.03127821323
    [Google Scholar]
/content/journals/cmir/10.2174/0115734056327323250108055841
Loading
/content/journals/cmir/10.2174/0115734056327323250108055841
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test